US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalI
IGC
IGC Pharma Inc
0.34
0.00+0.06%Opening12:43 09/19 EDT
OPEN/PREV CLOSE0.3451/0.3400
TODAY RANGE0.3333-0.3495
VOL105.49K
MARKET CAP25.73M
52 WEEK RANGE0.2501-0.9099
AVG VOL (3M)258.08K
% TURNOVER0.14%
TURNOVER--
P/E (TTM)-1.6169
% RANGE4.76%
EPS(TTM)-0.2104
P/E(FORWARD)-17.7440
P/B3.265
BVPS0.1042
DIVIDEND--
P/S16.84
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP23.69M
SHARES OUTSTANDING75.64M
NEXT EARNINGS11/07-11/11
FREE FLOAT69.65M
LOT SIZE1
EX-DIV DATE04/19/2013
News
Press Releases
Financial Reports
Profile
Benzinga·09/03 12:00
The Analyst Verdict: IGC Pharma In The Eyes Of 4 Experts
Dow Jones·09/03 09:58
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones·09/03 09:58
IGC Pharma Price Target Raised to $3.75/Share From $3.50 by Ascendiant Capital
Benzinga·09/03 09:48
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $3.75
Investorplace·08/12 15:52
IGC Stock Earnings: IGC Pharma Beats EPS, Misses Revenue for Q1 2025
Benzinga·08/09 13:24
IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research
Seeking Alpha·08/09 07:33
India Globalization Capital GAAP EPS of -$0.03 in-line, revenue of $0.27M misses by $0.04M
Dow Jones·08/09 01:30
*IGC Pharma 1Q Loss/Shr 3c >IGC
Dow Jones·08/09 01:30
Press Release: IGC Pharma Reports First Quarter Fiscal 2025 Results
Dow Jones·08/09 01:30
Press Release: IGC Pharma Reports First Quarter -2-
Dow Jones·07/29 11:07
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Same Industry
Name/Symbol
Change%
Price